psilocybin treatment Search Results


psilocybin treatment  (Usona Institute Inc)
90
Usona Institute Inc psilocybin treatment
An overview of the characteristics of <t>psilocybin.</t> The diagram includes the chemical structures of psilocybin and its metabolite. The bold lines indicate similarities in the chemical structure between this psychedelic and serotonin. In addition, the enzymes and major organs involved in the metabolism and excretion of psilocybin are indicated. The mechanism of action represents the targets of the psychedelic, both the region of the brain affected by the psychedelic and the receptors with which it interacts (pink circle for agonist). 5HT—serotonin receptors (2Ar, 1Ar, 2Cr, – subtypes). IP3, inositol-3-phosphate; cAMP, cyclic adenosine monophosphate.
Psilocybin Treatment, supplied by Usona Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psilocybin treatment/product/Usona Institute Inc
Average 90 stars, based on 1 article reviews
psilocybin treatment - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
using psilocybin to identify a candidate therapeutic agent for treatment of a cognitive deficit.  (Galenea Inc)
90
Galenea Inc using psilocybin to identify a candidate therapeutic agent for treatment of a cognitive deficit.
An overview of the characteristics of <t>psilocybin.</t> The diagram includes the chemical structures of psilocybin and its metabolite. The bold lines indicate similarities in the chemical structure between this psychedelic and serotonin. In addition, the enzymes and major organs involved in the metabolism and excretion of psilocybin are indicated. The mechanism of action represents the targets of the psychedelic, both the region of the brain affected by the psychedelic and the receptors with which it interacts (pink circle for agonist). 5HT—serotonin receptors (2Ar, 1Ar, 2Cr, – subtypes). IP3, inositol-3-phosphate; cAMP, cyclic adenosine monophosphate.
Using Psilocybin To Identify A Candidate Therapeutic Agent For Treatment Of A Cognitive Deficit., supplied by Galenea Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/using psilocybin to identify a candidate therapeutic agent for treatment of a cognitive deficit./product/Galenea Inc
Average 90 stars, based on 1 article reviews
using psilocybin to identify a candidate therapeutic agent for treatment of a cognitive deficit. - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
clinical trials assessing the use of psilocybin in an treatment  (Johns Hopkins HealthCare)
90
Johns Hopkins HealthCare clinical trials assessing the use of psilocybin in an treatment
Novel treatments to target anorexia nervosa core and associated behaviors.
Clinical Trials Assessing The Use Of Psilocybin In An Treatment, supplied by Johns Hopkins HealthCare, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/clinical trials assessing the use of psilocybin in an treatment/product/Johns Hopkins HealthCare
Average 90 stars, based on 1 article reviews
clinical trials assessing the use of psilocybin in an treatment - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
psilocybin treatment  (Compass Pathways Ltd)
86
Compass Pathways Ltd psilocybin treatment
Novel treatments to target anorexia nervosa core and associated behaviors.
Psilocybin Treatment, supplied by Compass Pathways Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/psilocybin treatment/product/Compass Pathways Ltd
Average 86 stars, based on 1 article reviews
psilocybin treatment - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


An overview of the characteristics of psilocybin. The diagram includes the chemical structures of psilocybin and its metabolite. The bold lines indicate similarities in the chemical structure between this psychedelic and serotonin. In addition, the enzymes and major organs involved in the metabolism and excretion of psilocybin are indicated. The mechanism of action represents the targets of the psychedelic, both the region of the brain affected by the psychedelic and the receptors with which it interacts (pink circle for agonist). 5HT—serotonin receptors (2Ar, 1Ar, 2Cr, – subtypes). IP3, inositol-3-phosphate; cAMP, cyclic adenosine monophosphate.

Journal: Frontiers in Pharmacology

Article Title: Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

doi: 10.3389/fphar.2022.927984

Figure Lengend Snippet: An overview of the characteristics of psilocybin. The diagram includes the chemical structures of psilocybin and its metabolite. The bold lines indicate similarities in the chemical structure between this psychedelic and serotonin. In addition, the enzymes and major organs involved in the metabolism and excretion of psilocybin are indicated. The mechanism of action represents the targets of the psychedelic, both the region of the brain affected by the psychedelic and the receptors with which it interacts (pink circle for agonist). 5HT—serotonin receptors (2Ar, 1Ar, 2Cr, – subtypes). IP3, inositol-3-phosphate; cAMP, cyclic adenosine monophosphate.

Article Snippet: Subsequently, the FDA also designated “breakthrough therapy” status to psilocybin treatment for MDD in trials financially supported by the Usona Institute ( ).

Techniques:

The common adverse effects related to psilocybin exposure.

Journal: Frontiers in Pharmacology

Article Title: Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

doi: 10.3389/fphar.2022.927984

Figure Lengend Snippet: The common adverse effects related to psilocybin exposure.

Article Snippet: Subsequently, the FDA also designated “breakthrough therapy” status to psilocybin treatment for MDD in trials financially supported by the Usona Institute ( ).

Techniques:

An overview of the characteristics of DMT. The diagram includes the chemical structures of DMT and its metabolite. The bold lines indicate similarities in the chemical structure between this psychedelic and serotonin. In addition, the enzymes and major organs involved in the metabolism and excretion of psilocybin are indicated. The mechanism of action represents the targets of the psychedelic, both the region of the brain affected by the psychedelic and the receptors with which it interacts (pink circle for agonist). 5HT—serotonin receptors (2Ar, 2Cr,—subtypes), sigma 1 receptor. MAOI, monoamine oxidase I; IP3, inositol-3-phosphate; ER, endoplasmic reticulum.

Journal: Frontiers in Pharmacology

Article Title: Three Naturally-Occurring Psychedelics and Their Significance in the Treatment of Mental Health Disorders

doi: 10.3389/fphar.2022.927984

Figure Lengend Snippet: An overview of the characteristics of DMT. The diagram includes the chemical structures of DMT and its metabolite. The bold lines indicate similarities in the chemical structure between this psychedelic and serotonin. In addition, the enzymes and major organs involved in the metabolism and excretion of psilocybin are indicated. The mechanism of action represents the targets of the psychedelic, both the region of the brain affected by the psychedelic and the receptors with which it interacts (pink circle for agonist). 5HT—serotonin receptors (2Ar, 2Cr,—subtypes), sigma 1 receptor. MAOI, monoamine oxidase I; IP3, inositol-3-phosphate; ER, endoplasmic reticulum.

Article Snippet: Subsequently, the FDA also designated “breakthrough therapy” status to psilocybin treatment for MDD in trials financially supported by the Usona Institute ( ).

Techniques:

Novel treatments to target anorexia nervosa core and associated behaviors.

Journal: Expert opinion on pharmacotherapy

Article Title: Pharmacotherapeutic strategies for the treatment of anorexia nervosa – novel targets to break a vicious cycle

doi: 10.1080/14656566.2024.2424316

Figure Lengend Snippet: Novel treatments to target anorexia nervosa core and associated behaviors.

Article Snippet: Of note, Johns Hopkins University ( NCT04052568 ) and Imperial College London ( NCT04505189 ) have completed clinical trials assessing the use of psilocybin in AN treatment.

Techniques: Drug discovery, Activity Assay, Concentration Assay